Kyverna Therapeutics, Inc.
KYTX
Revenue
0.00
0.000.00%
-Assets
226.51M
▼-34.15M▼-13.10%
3 Months ChangeLiabilities
42.13M
▲5.49M▲14.97%
3 Months ChangeFree Cash Flow
-44.92M
▼-18.85M▼-72.30%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-21
Form 8-K
ID: 0001213900-24-089095
2024-09-16
Form 8-K
ID: 0001213900-24-078736
2024-08-12
Form 10-Q
ID: 0000950170-24-095462
2024-08-12
Form 8-K
ID: 0000950170-24-095433
2024-07-15
Form 8-K
ID: 0000950170-24-083570
2024-06-14
Form 8-K
ID: 0000950170-24-073312
2024-05-14
Form 10-Q
ID: 0000950170-24-059628
2024-05-14
Form 8-K
ID: 0000950170-24-059613
2024-03-26
Form 8-K
ID: 0000950170-24-036410
2024-02-12
Form 8-K
ID: 0001193125-24-032161